InvestorsHub Logo

Restingzebra

09/25/20 9:50 AM

#301479 RE: rafunrafun #301473

Thank R.

dukesking

09/25/20 9:50 AM

#301480 RE: rafunrafun #301473

Thanks Raf.

lizzy241

09/25/20 9:52 AM

#301481 RE: rafunrafun #301473

thx raf, lookin good

Level2Me

09/25/20 3:33 PM

#301587 RE: rafunrafun #301473

cheers

Jasbg

09/25/20 6:11 PM

#301630 RE: rafunrafun #301473

raf@ A thought - maybe not bright - but still A Thought :)

Knowing that it's actually Teva - selling Lovaza - you could look at that as a blockage for making a Partner deal with Teva for Vascepa.
-------------------------

But if you turn it around - Teva is 'exactly the right partner for this. Instead of 'fighting Amarin' - loosing Lovaza marked all the time, Teva can go out into the world and announce:

"We now have the wunder drug that over the next months will replace Lovaza - and this drug will be on of the biggest and most important drugs for humanity ever - with potential to save hundreds of millions of CDV patients Worldwide".
--------------------------

Idea: Teva would have 'both groups of customers' from the start. And they could just 'nice and easy' transfer earlier Lovaza patients to Vascepa - in the tempo where logistics and production would be able to handle it.

Teva would benefit - sky would be the limit for expansion of new Vascepa customers WW. CDV patient all over planet earth would benefit - a total WIN - WIN :)

Jasbg